Free fatty acids and their metabolism affect function and survival of podocytes

Frontiers in Endocrinology

Volumn 5, Issue OCT, 2014, Pages

  Sieber, Jonas ^a   Jehle, Andreas Werner ^b  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b UNIVERSITY HOSPITAL BASEL   (Switzerland)

Author keywords

Diabetic nephropathy; Endoplasmic reticulum stress; Lipid metabolism; Lipotoxicity; Podocyte; Saturated and monounsaturated free fatty acids; oxidation

Indexed keywords

ADOLESCENT; ADULT; ASSAULT; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; DISEASE ASSOCIATION; FACE INJURY; FEMALE; HEAD INJURY; HUMAN; MAJOR CLINICAL STUDY; MALE; REVIEW; THREE DIMENSIONAL IMAGING; TRAFFIC ACCIDENT;

EID: 84930634650     PISSN: None     EISSN: 16642392     Source Type: Journal    
DOI: 10.3389/fendo.2014.00186     Document Type: Review

References (82)

1. USRDS: the United States renal data system. Am J Kidney Dis (2003) 42(6 Suppl 5):1-230.
2. Locatelli F, Pozzoni P, Del Vecchio L. Renal replacement therapy in patients with diabetes and end-stage renal disease. J Am Soc Nephrol (2004) 15(Suppl 1):S25-9. doi: 10.1097/01.ASN.0000093239.32602.04
3. Dalla Vestra M, Masiero A, Roiter AM, Saller A, Crepaldi G, Fioretto P. Is podocyte injury relevant in diabetic nephropathy? Studies in patients with type 2 diabetes. Diabetes (2003) 52(4):1031-5. doi:10.2337/diabetes.52.4.1031
4. Pagtalunan ME, Miller PL, Jumping-Eagle S, Nelson RG, Myers BD, Rennke HG, et al. Podocyte loss and progressive glomerular injury in type II diabetes. J Clin Invest (1997) 99(2):342-8. doi:10.1172/JCI119163
5. White KE, Bilous RW; Diabiopsies Study Group. Structural alterations to the podocyte are related to proteinuria in type 2 diabetic patients. Nephrol Dial Transplant (2004) 19(6):1437-40. doi:10.1093/ndt/gfh129
6. Chen HM, Liu ZH, Zeng CH, Li SJ, Wang QW, Li LS. Podocyte lesions in patients with obesity-related glomerulopathy. Am J Kidney Dis (2006) 48(5):772-9. doi:10.1053/j.ajkd.2006.04.079
7. Coresh J, Selvin E, Stevens LA, Manzi J, Kusek JW, Eggers P, et al. Prevalence of chronic kidney disease in the United States. JAMA (2007) 298(17):2038-47. doi:10.1001/jama.298.17.2038
8. Eckardt KU, Coresh J, Devuyst O, Johnson RJ, Köttgen A, Levey AS, et al. Evolving importance of kidney disease: from subspecialty to global health burden. Lancet (2013) 382(9887):158-69. doi:10.1016/S0140-6736(13)60439-0
9. de Vries AP, Ruggenenti P, Ruan XZ, Praga M, Cruzado JM, Bajema IM, et al. Fatty kidney: emerging role of ectopic lipid in obesity-related renal disease. Lancet Diabetes Endocrinol (2014) 2(5):417-26. doi:10.1016/S2213-8587(14)70065-8
10. Verani RR. Obesity-associated focal segmental glomerulosclerosis: pathological features of the lesion and relationship with cardiomegaly and hyperlipidemia. Am J Kidney Dis (1992) 20(6):629-34. doi:10.1016/S0272-6386(12)70230-5
11. Herman-Edelstein M, Scherzer P, Tobar A, Levi M, Gafter U. Altered renal lipid metabolism and renal lipid accumulation in human diabetic nephropathy. J Lipid Res (2014) 55(3):561-72. doi:10.1194/jlr. P040501
12. Merscher-Gomez S, Guzman J, Pedigo CE, Lehto M, Aguillon-Prada R, Mendez A, et al. Cyclodextrin protects podocytes in diabetic kidney disease. Diabetes (2013) 62(11):3817-27. doi:10.2337/db13-0399
13. Lafontan M, Langin D. Lipolysis and lipid mobilization in human adipose tissue. Prog Lipid Res (2009) 48(5):275-97. doi:10.1016/j.plipres.2009.05.001
14. Teusink B, Voshol PJ, Dahlmans VE, Rensen PC, Pijl H, Romijn JA, et al. Contribution of fatty acids released from lipolysis of plasma triglycerides to total plasma fatty acid flux and tissue-specific fatty acid uptake. Diabetes (2003) 52(3):614-20. doi:10.2337/diabetes.52.3.614
15. Reaven GM, Hollenbeck C, Jeng CY, Wu MS, Chen YD. Measurement of plasma glucose, free fatty acid, lactate, and insulin for 24 h in patients with NIDDM. Diabetes (1988) 37(8):1020-4. doi:10.2337/diabetes.37.1.28
16. Karpe F, Dickmann JR, Frayn KN. Fatty acids, obesity, and insulin resistance: time for a reevaluation. Diabetes (2011) 60(10):2441-9. doi:10.2337/db11-0425
17. Engfeldt P, Arner P. Lipolysis in human adipocytes, effects of cell size, age and of regional differences. Horm Metab Res Suppl (1988) 19:26-9.
18. Lionetti L, Mollica MP, Lombardi A, Cavaliere G, Gifuni G, Barletta A. From chronic overnutrition to insulin resistance: the role of fat-storing capacity and inflammation. Nutr Metab Cardiovasc Dis (2009) 19(2):146-52. doi:10.1016/j.numecd.2008.10.010
19. Eckel RH, Grundy SM, Zimmet PZ. The metabolic syndrome. Lancet (2005) 365(9468):1415-28. doi:10.1016/S0140-6736(05)66378-7
20. Roden M, Price TB, Perseghin G, Petersen KF, Rothman DL, Cline GW, et al. Mechanism of free fatty acid-induced insulin resistance in humans. J Clin Invest (1996) 97(12):2859-65. doi:10.1172/JCI118742
21. McQuaid SE, Hodson L, Neville MJ, Dennis AL, Cheeseman J, Humphreys SM, et al. Downregulation of adipose tissue fatty acid trafficking in obesity: a driver for ectopic fat deposition? Diabetes (2011) 60(1):47-55. doi:10.2337/db10-0867
22. Fielding BA, Callow J, Owen RM, Samra JS, Matthews DR, Frayn KN. Postprandial lipemia: the origin of an early peak studied by specific dietary fatty acid intake during sequential meals. Am J Clin Nutr (1996) 63(1):36-41.
23. Estruch R, Ros E, Salas-Salvado J, Covas MI, Corella D, Aros F, et al. Primary prevention of cardiovascular disease with a Mediterranean diet. N Engl J Med (2013) 368(14):1279-90. doi:10.1056/NEJMoa1200303
24. Salas-Salvadó J, Bulló M, Estruch R, Ros E, Covas MI, Ibarrola-Jurado N, et al. Prevention of diabetes with Mediterranean diets: a subgroup analysis of a randomized trial. Ann Intern Med (2014) 160(1):1-10. doi:10.7326/m13-1725
25. Hagenfeldt L, Wahren J, Pernow B, Räf L. Uptake of individual free fatty acids by skeletal muscle and liver in man. J Clin Invest (1972) 51(9):2324-30. doi:10.1172/JCI107043
26. Raclot T, Langin D, Lafontan M, Groscolas R. Selective release of human adipocyte fatty acids according to molecular structure. Biochem J (1997) 324(Pt 3):911-5.
27. Lennon R, Pons D, Sabin MA, Wei C, Shield JP, Coward RJ, et al. Saturated fatty acids induce insulin resistance in human podocytes: implications for diabetic nephropathy. Nephrol Dial Transplant (2009) 24(11):3288-96. doi:10.1093/ndt/gfp302
28. Sieber J, Lindenmeyer MT, Kampe K, Campbell KN, Cohen CD, Hopfer H, et al. Regulation of podocyte survival and endoplasmic reticulum stress by fatty acids. Am J Physiol Renal Physiol (2010) 299(4):F821-9. doi:10.1152/ajprenal.00196.2010
29. Prentki M, Madiraju SR. Glycerolipid metabolism and signaling in health and disease. Endocr Rev (2008) 29(6):647-76. doi:10.1210/er.2008-0007
30. Novgorodov SA, Szulc ZM, Luberto C, Jones JA, Bielawski J, Bielawska A, et al. Positively charged ceramide is a potent inducer of mitochondrial permeabilization. J Biol Chem (2005) 280(16):16096-105. doi:10.1074/jbc. M411707200
31. Galadari S, Rahman A, Pallichankandy S, Galadari A, Thayyullathil F. Role of ceramide in diabetes mellitus: evidence and mechanisms. Lipids Health Dis (2013) 12:98. doi:10.1186/1476-511X-12-98
32. Griner EM, Kazanietz MG. Protein kinase C and other diacylglycerol effectors in cancer. Nat Rev Cancer (2007) 7(4):281-94. doi:10.1038/nrc2110
33. Maedler K, Spinas GA, Dyntar D, Moritz W, Kaiser N, Donath MY. Distinct effects of saturated and monounsaturated fatty acids on beta-cell turnover and function. Diabetes (2001) 50(1):69-76. doi:10.2337/diabetes.50.1.69
34. Listenberger LL, Ory DS, Schaffer JE. Palmitate-induced apoptosis can occur through a ceramide-independent pathway. J Biol Chem (2001) 276(18):14890-5. doi:10.1074/jbc. M010286200
35. Nolan CJ, Larter CZ. Lipotoxicity: why do saturated fatty acids cause and monounsaturates protect against it? J Gastroenterol Hepatol (2009) 24(5):703-6. doi:10.1111/j.1440-1746.2009.05823.x
36. Baldwin AC, Green CD, Olson LK, Moxley MA, Corbett JA. A role for aberrant protein palmitoylation in FFA-induced ER stress and ß-cell death. Am J Physiol Endocrinol Metab (2012) 302(11):E1390-8. doi:10.1152/ajpendo.00519.2011
37. Sieber J, Weins A, Kampe K, Gruber S, Lindenmeyer MT, Cohen CD, et al. Susceptibility of podocytes to palmitic acid is regulated by stearoyl-CoA desaturases 1 and 2. Am J Pathol (2013) 183(3):735-44. doi:10.1016/j.ajpath.2013.05.023
38. Kampe K, Sieber J, Orellana JM, Mundel P, Jehle AW. Susceptibility of podocytes to palmitic acid is regulated by fatty acid oxidation and inversely depends on acetyl-CoA carboxylases 1 and 2. Am J Physiol Renal Physiol (2014) 306(4):F401-9. doi:10.1152/ajprenal.00454.2013
39. Nakamura S, Takamura T, Matsuzawa-Nagata N, Takayama H, Misu H, Noda H, et al. Palmitate induces insulin resistance in H4IIEC3 hepatocytes through reactive oxygen species produced by mitochondria. J Biol Chem (2009) 284(22):14809-18. doi:10.1074/jbc. M901488200
40. Solinas G, Naugler W, Galimi F, Lee MS, Karin M. Saturated fatty acids inhibit induction of insulin gene transcription by JNK-mediated phosphorylation of insulin-receptor substrates. Proc Natl Acad Sci U S A (2006) 103(44):16454-9. doi:10.1073/pnas.0607626103
41. Turban S, Hajduch E. Protein kinase C isoforms: mediators of reactive lipid metabolites in the development of insulin resistance. FEBS Lett (2011) 585(2):269-74. doi:10.1016/j.febslet.2010.12.022
42. Mima A, Ohshiro Y, Kitada M, Matsumoto M, Geraldes P, Li C, et al. Glomerular-specific protein kinase C-ß-induced insulin receptor substrate-1 dysfunction and insulin resistance in rat models of diabetes and obesity. Kidney Int (2011) 79(8):883-96. doi:10.1038/ki.2010.526
43. Welsh GI, Hale LJ, Eremina V, Jeansson M, Maezawa Y, Lennon R, et al. Insulin signaling to the glomerular podocyte is critical for normal kidney function. Cell Metab (2010) 12(4):329-40. doi:10.1016/j.cmet.2010.08.015
44. Back SH, Kaufman RJ. Endoplasmic reticulum stress and type 2 diabetes. Annu Rev Biochem (2012) 81:767-93. doi:10.1146/annurev-biochem-072909-095555
45. Ozcan U, Yilmaz E, Ozcan L, Furuhashi M, Vaillancourt E, Smith RO, et al. Chemical chaperones reduce ER stress and restore glucose homeostasis in a mouse model of type 2 diabetes. Science (2006) 313(5790):1137-40. doi:10.1126/science.1128294
46. Lindenmeyer MT, Rastaldi MP, Ikehata M, Neusser MA, Kretzler M, Cohen CD, et al. Proteinuria and hyperglycemia induce endoplasmic reticulum stress. J Am Soc Nephrol (2008) 19(11):2225-36. doi:10.1681/ASN.2007121313
47. Cunard R, Sharma K. The endoplasmic reticulum stress response and diabetic kidney disease. Am J Physiol Renal Physiol (2011) 300(5):F1054-61. doi:10.1152/ajprenal.00021.2011
48. Luo ZF, Feng B, Mu J, Qi W, Zeng W, Guo YH, et al. Effects of 4-phenylbutyric acid on the process and development of diabetic nephropathy induced in rats by streptozotocin: regulation of endoplasmic reticulum stress-oxidative activation. Toxicol Appl Pharmacol (2010) 246(1-2):49-57. doi:10.1016/j.taap.2010.04.005
49. Qi W, Mu J, Luo ZF, Zeng W, Guo YH, Pang Q, et al. Attenuation of diabetic nephropathy in diabetes rats induced by streptozotocin by regulating the endoplasmic reticulum stress inflammatory response. Metabolism (2011) 60(5):594-603. doi:10.1016/j.metabol.2010.07.021
50. Kaufman RJ. Orchestrating the unfolded protein response in health and disease. J Clin Invest (2002) 110(10):1389-98. doi:10.1172/JCI200216886
51. Ma Y, Hendershot LM. The unfolding tale of the unfolded protein response. Cell (2001) 107(7):827-30. doi:10.1016/S0092-8674(01)00623-7
52. Rasheva VI, Domingos PM. Cellular responses to endoplasmic reticulum stress and apoptosis. Apoptosis (2009) 14(8):996-1007. doi:10.1007/s10495-009-0341-y
53. Travers KJ, Patil CK, Wodicka L, Lockhart DJ, Weissman JS, Walter P. Functional and genomic analyses reveal an essential coordination between the unfolded protein response and ER-associated degradation. Cell (2000) 101(3):249-58. doi:10.1016/S0092-8674(00)80835-1
54. Lee AH, Iwakoshi NN, Glimcher LH. XBP-1 regulates a subset of endoplasmic reticulum resident chaperone genes in the unfolded protein response. Mol Cell Biol (2003) 23(21):7448-59. doi:10.1128/MCB.23.23.8913-8923.2003
55. Acosta-Alvear D, Zhou Y, Blais A, Tsikitis M, Lents NH, Arias C, et al. XBP1 controls diverse cell type- and condition-specific transcriptional regulatory networks. Mol Cell (2007) 27(1):53-66. doi:10.1016/j.molcel.2007.06.011
56. Laybutt DR, Preston AM, Akerfeldt MC, Kench JG, Busch AK, Biankin AV, et al. Endoplasmic reticulum stress contributes to beta cell apoptosis in type 2 diabetes. Diabetologia (2007) 50(4):752-63. doi:10.1007/s00125-007-0749-2
57. Yasuda M, Tanaka Y, Kume S, Morita Y, Chin-Kanasaki M, Araki H, et al. Fatty acids are novel nutrient factors to regulate mTORC1 lysosomal localization and apoptosis in podocytes. Biochim Biophys Acta (2014) 1842(7):1097-108. doi:10.1016/j.bbadis.2014.04.001
58. Wu J, Zhang R, Torreggiani M, Ting A, Xiong H, Striker GE, et al. Induction of diabetes in aged C57B6 mice results in severe nephropathy: an association with oxidative stress, endoplasmic reticulum stress, and inflammation. Am J Pathol (2010) 176(5):2163-76. doi:10.2353/ajpath.2010.090386
59. Oyadomari S, Mori M. Roles of CHOP/GADD153 in endoplasmic reticulum stress. Cell Death Differ (2004) 11(4):381-9. doi:10.1038/sj.cdd.4401373
60. Marciniak SJ, Yun CY, Oyadomari S, Novoa I, Zhang Y, Jungreis R, et al. CHOP induces death by promoting protein synthesis and oxidation in the stressed endoplasmic reticulum. Genes Dev (2004) 18(24):3066-77. doi:10.1101/gad.1250704
61. Yamaguchi H, Wang HG. CHOP is involved in endoplasmic reticulum stress-induced apoptosis by enhancing DR5 expression in human carcinoma cells. J Biol Chem (2004) 279(44):45495-502. doi:10.1074/jbc. M406933200
62. Li G, Mongillo M, Chin KT, Harding H, Ron D, Marks AR, et al. Role of ERO1-alpha-mediated stimulation of inositol 1,4,5-triphosphate receptor activity in endoplasmic reticulum stress-induced apoptosis. J Cell Biol (2009) 186(6):783-92. doi:10.1083/jcb.200904060
63. McCullough KD, Martindale JL, Klotz LO, Aw TY, Holbrook NJ. Gadd153 sensitizes cells to endoplasmic reticulum stress by down-regulating Bcl2 and perturbing the cellular redox state. Mol Cell Biol (2001) 21(4):1249-59. doi:10.1128/MCB.21.4.1249-1259.2001
64. Borradaile NM, Han X, Harp JD, Gale SE, Ory DS, Schaffer JE. Disruption of endoplasmic reticulum structure and integrity in lipotoxic cell death. J Lipid Res (2006) 47(12):2726-37. doi:10.1194/jlr. M600299-JLR200
65. Promlek T, Ishiwata-Kimata Y, Shido M, Sakuramoto M, Kohno K, Kimata Y. Membrane aberrancy and unfolded proteins activate the endoplasmic reticulum stress sensor Ire1 in different ways. Mol Biol Cell (2011) 22(18):3520-32. doi:10.1091/mbc. E11-04-0295
66. Preston AM, Gurisik E, Bartley C, Laybutt DR, Biden TJ. Reduced endoplasmic reticulum (ER)-to-Golgi protein trafficking contributes to ER stress in lipotoxic mouse beta cells by promoting protein overload. Diabetologia (2009) 52(11):2369-73. doi:10.1007/s00125-009-1506-5
67. Maurel M, Chevet E, Tavernier J, Gerlo S. Getting RIDD of RNA: IRE1 in cell fate regulation. Trends Biochem Sci (2014) 39(5):245-54. doi:10.1016/j.tibs.2014.02.008
68. Chen Y, Brandizzi F. IRE1: ER stress sensor and cell fate executor. Trends Cell Biol (2013) 23(11):547-55. doi:10.1016/j.tcb.2013.06.005
69. Guo ZK, Jensen MD. Accelerated intramyocellular triglyceride synthesis in skeletal muscle of high-fat-induced obese rats. Int J Obes Relat Metab Disord (2003) 27(9):1014-9. doi:10.1038/sj.ijo.0802380
70. Zhang XJ, Chinkes DL, Wu Z, Herndon DN, Wolfe RR. The synthetic rate of muscle triglyceride but not phospholipid is increased in obese rabbits. Metabolism (2009) 58(11):1649-56. doi:10.1016/j.metabol.2009.05.021
71. Maeda S, Kobayashi MA, Araki S, Babazono T, Freedman BI, Bostrom MA, et al. A single nucleotide polymorphism within the acetyl-coenzyme A carboxylase beta gene is associated with proteinuria in patients with type 2 diabetes. PLoS Genet (2010) 6(2):e1000842. doi:10.1371/journal.pgen.1000842
72. Tang SC, Leung VT, Chan LY, Wong SS, Chu DW, Leung JC, et al. The acetyl-coenzyme A carboxylase beta (ACACB) gene is associated with nephropathy in Chinese patients with type 2 diabetes. Nephrol Dial Transplant (2010) 25(12):3931-4. doi:10.1093/ndt/gfq303
73. Shah VN, Cheema BS, Sharma R, Khullar M, Kohli HS, Ahluwalia TS, et al. ACACbeta gene (rs2268388) and AGTR1 gene (rs5186) polymorphism and the risk of nephropathy in Asian Indian patients with type 2 diabetes. Mol Cell Biochem (2013) 372(1-2):191-8. doi:10.1007/s11010-012-1460-2
74. Sharma K, Ramachandrarao S, Qiu G, Usui HK, Zhu Y, Dunn SR, et al. Adiponectin regulates albuminuria and podocyte function in mice. J Clin Invest (2008) 118(5):1645-56. doi:10.1172/JCI32691
75. Listenberger LL, Han X, Lewis SE, Cases S, Farese RV, Ory DS, et al. Triglyceride accumulation protects against fatty acid-induced lipotoxicity. Proc Natl Acad Sci U S A (2003) 100(6):3077-82. doi:10.1073/pnas.0630588100
76. Yen CL, Stone SJ, Koliwad S, Harris C, Farese RV Jr. Thematic review series: glycerolipids. DGAT enzymes and triacylglycerol biosynthesis. J Lipid Res (2008) 49(11):2283-301. doi:10.1194/jlr. R800018-JLR200
77. Mittendorfer B. Origins of metabolic complications in obesity: adipose tissue and free fatty acid trafficking. Curr Opin Clin Nutr Metab Care (2011) 14(6):535-41. doi:10.1097/MCO.0b013e32834ad8b6
78. Goodpaster BH, He J, Watkins S, Kelley DE. Skeletal muscle lipid content and insulin resistance: evidence for a paradox in endurance-trained athletes. J Clin Endocrinol Metab (2001) 86(12):5755-61. doi:10.1210/jcem.86.12.8075
79. Liu L, Shi X, Bharadwaj KG, Ikeda S, Yamashita H, Yagyu H, et al. DGAT1 expression increases heart triglyceride content but ameliorates lipotoxicity. J Biol Chem (2009) 284(52):36312-23. doi:10.1074/jbc. M109.049817
80. Benhamed F, Denechaud PD, Lemoine M, Robichon C, Moldes M, Bertrand-Michel J, et al. The lipogenic transcription factor ChREBP dissociates hepatic steatosis from insulin resistance in mice and humans. J Clin Invest (2012) 122(6):2176-94. doi:10.1172/JCI41636
81. Jiang T, Wang XX, Scherzer P, Wilson P, Tallman J, Takahashi H, et al. Farnesoid X receptor modulates renal lipid metabolism, fibrosis, and diabetic nephropathy. Diabetes (2007) 56(10):2485-93. doi:10.2337/db06-1642
82. Wang XX, Jiang T, Shen Y, Adorini L, Pruzanski M, Gonzalez FJ, et al. The farnesoid X receptor modulates renal lipid metabolism and diet-induced renal inflammation, fibrosis, and proteinuria. Am J Physiol Renal Physiol (2009) 297(6):F1587-96. doi:10.1152/ajprenal.00404.2009